‘Cure or nothing’ doesn’t capture the realities of modern cancer research and treatment 23 Dec 2019 While curing cancer will always be the ultimate goal for the ICR's researchers, Professor Paul Workman argues that it's vital we understand and accept new evolutionary approaches to treatment that can control even advanced cancers long term. Find out more Show/Hide
UK science needs a clear plan for the future 28 Jun 2019 If science in the UK is going to remain world class, it’s crucial that we have a clear plan for the future that secures research funding, ensures freedom for scientists to work across borders, and provides regulatory alignment, argues the ICR’s Chief Executive Professor Paul Workman. Find out more Show/Hide
Our manifesto for cancer drug discovery and development – focusing on innovation to tackle treatment resistance and meeting patients’ needs 30 Apr 2019 Professor Paul Workman argues that concerted action is needed to accelerate patients’ access to today’s new treatments – and incentivise creation of the innovative new medicines of tomorrow that will lead to step changes in clinical outcome. Find out more Show/Hide
Why regulators must move with the science if we’re to get innovative new treatments to patients more quickly 05 Dec 2018
Tribute to Patrick (Paddy) Johnston – a true leader and champion of cancer research and cancer patients 12 Jun 2017